… Combining cutting-edge technologies and medical brilliance under one roof to bring healthcare standards in Dubai to international heights
The healthcare sector is set to witness a leap in the UAE with Clemenceau Medical Center hospital Dubai – a center of excellence for diagnosis and treatment across several health specialties in the United Arab Emirates (UAE) – acquiring innovative robotic surgery technologies that allow the hospital to perform minimally invasive surgeries, including the da Vinci Surgical System which promises to transform patient care in the country.
Clemenceau Medical Center hospital Dubai is one of the few hospitals in Dubai and the region to offer this type of surgeries in multiple specialties led by a team of expert surgeons including: Dr. Rabii Madi (Urinary, Kidney & Prostate Tract Surgeon), Dr. Ayman Harakeh (Gastroenterology, Colon & Obesity Surgeon), and gynecologic surgeons Dr. Elias Abi Khalil, Dr. Abdul Karim Nofal and Dr. Labib Riachi.
The newest da Vinci robot does not replace the skills and expertise of surgeons. Instead, it offers them the robust technology that enables them to perform complex surgeries with more precision. In fact, the da Vinci Surgical System boasts 4 robotic arms commanded by the surgeon through a computer that offers a 3D high-definition view of the surgical field.
Commenting on the importance of acquiring the da Vinci robotic technology, Dr. Rabii Madi said: “Robotic surgery has established itself as one of the most important and promising breakthroughs in medical innovation as it greatly expands our surgical capabilities and allows us to work with extreme precision on microscopic parts of the human body, which helps us make a difference on many levels. The advanced lens system magnifies body parts by 10 times their normal size, allowing us to perform highly precise minimally invasive procedures through a very small, 8-mm incision. Also, the robotic arms and specialized instruments that come with the system extend the capabilities of our eyes and hands, enabling us to work with extreme accuracy and move with ease. As a result, we are able to provide our patients with more effective treatments while reducing the possibility of blood loss and human errors; significantly improving the appearance of surgical scars; speeding up surgeries, hospital stay and recovery period; and alleviating pain.”
da Vinci is used in multiple disciplines to treat a range of conditions in general surgery (obesity, stomach cancer, reflux, hernia); in urologic surgery (prostate, kidney and bladder cancers); and in gynecologic surgery (removal of the uterus or uterine fibroids, ovarian diseases, organ prolapse and gynecologic cancers).
Talking about the impact of the surgical system on the healthcare industry, Mr. Abdul Rahman Khansaheb, Chairman of the Clemenceau Medical Center hospital Dubai, said: “Providing robotic-assisted surgeries at Clemenceau Medical Center represents significant progress in medical and healthcare, knowing that patients no longer need to travel abroad to benefit from technological advancements as they can have access to them here in Dubai. Investing in this type of global technology reflects our ongoing commitment to providing premium healthcare in the UAE, allowing our patients to enjoy peace of mind and feel in safe hands.”
From his end, Dr. Mounes Kalaawi, Chairman and CEO of Clemenceau Medicine International (CMI), said: “The introduction of robotic surgery at Clemenceau Medical Center hospital Dubai is a landmark in the history of medicine in Dubai and the region. This new technology positions our hospital at the forefront of leading-edge procedures, medically and technologically, and shows our full commitment to making the investment needed for our patients to benefit from groundbreaking technologies, led by brilliant medical specialists, as it is the case in all Clemenceau Medicine International hospitals.”